Dena Michelle Godwin Hernandez is a neurogeneticist. She is head of the genomic technologies group in the laboratory of neurogenetics at the National Institute on Aging.[1]
Hernandez completed a Ph.D. at the UCL Queen Square Institute of Neurology in 2016. Her dissertation was titled Genetic variation and DNA methylation in the context of neurological disease. Hernandez's doctoral advisors were Andrew Singleton and John Hardy.[2]
References
- ↑ "Dena HERNANDEZ". National Institute on Aging. Retrieved 2021-10-01.
This article incorporates text from this source, which is in the public domain. - ↑ Hernandez, Dena Michelle Godwin (2016). Genetic variation and DNA methylation in the context of neurological disease (Ph.D. thesis). University College London. OCLC 1166871130.
This article incorporates public domain material from websites or documents of the National Institutes of Health.External links
- Dena G. Hernandez publications indexed by Google Scholar
- Dena G. Hernandez's publications indexed by the Scopus bibliographic database. (subscription required)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.